Deciphera Pharmaceuticals (DCPH) Tops Q2 EPS by 6c

Deciphera Pharmaceuticals (NASDAQ: DCPH) reported Q2 EPS of ($0.60), $0.06 better than the analyst estimate of ($0.66). Revenue for the quarter came in at $32.5 million versus the consensus estimate of $30.58 million.

For earnings history and earnings-related data on Deciphera Pharmaceuticals (DCPH) click here.

You May Also Be Interested In

• Microsoft invests $1.5 bln in Abu Dhabi AI firm G42, takes board seat
• Mitek Systems (MITK) Misses Q2 EPS by 4c, Offers Guidance
• FB Financial Corporation (FBK) Tops Q1 EPS by 15c